162 related articles for article (PubMed ID: 1690821)
21. Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients.
Busch MP; Lee TH; Heitman J
Blood; 1992 Oct; 80(8):2128-35. PubMed ID: 1391964
[TBL] [Abstract][Full Text] [Related]
22. Resistance to infection by HIV-1 of peripheral blood mononuclear cells from HIV-1-infected patients is probably mediated by neutralizing antibodies.
Tremblay M; Numazaki K; Li XG; Gornitsky M; Hiscott J; Wainberg MA
J Immunol; 1990 Nov; 145(9):2896-901. PubMed ID: 1698866
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.
Connor RI; Ho DD
J Virol; 1994 Jul; 68(7):4400-8. PubMed ID: 7515972
[TBL] [Abstract][Full Text] [Related]
24. Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection.
Anderson RE; Lang W; Shiboski S; Royce R; Jewell N; Winkelstein W
Arch Intern Med; 1990 Jan; 150(1):73-7. PubMed ID: 1967523
[TBL] [Abstract][Full Text] [Related]
25. Characterization of class I MHC folding intermediates and their disparate interactions with peptide and beta 2-microglobulin.
Smith JD; Solheim JC; Carreno BM; Hansen TH
Mol Immunol; 1995 May; 32(7):531-40. PubMed ID: 7783756
[TBL] [Abstract][Full Text] [Related]
26. Cytomegalovirus and beta 2 microglobulin in urine specimens. Reciprocal interference in their detection is responsible for artifactually high levels of urinary beta 2 microglobulin in infected transplant recipients.
Grundy JE; McKeating JA; Sanderson AR; Griffiths PD
Transplantation; 1988 Jun; 45(6):1075-9. PubMed ID: 2837846
[TBL] [Abstract][Full Text] [Related]
27. Relationship of anti-beta 2-microglobulin antibodies to T11 and T-cell activation in systemic lupus erythematosus.
Croghan TW; Minota S; Yamada A; Winfield JB
Clin Immunol Immunopathol; 1985 Nov; 37(2):179-90. PubMed ID: 3899432
[TBL] [Abstract][Full Text] [Related]
28. An antigenic determinant of human beta 2-microglobulin masked by the association with HLA heavy chains at the cell surface: analysis using monoclonal antibodies.
Liabeuf A; le Borgne de Kaouel C; Kourilsky FM; Malissen B; Manuel Y; Sanderson AR
J Immunol; 1981 Oct; 127(4):1542-8. PubMed ID: 6168695
[TBL] [Abstract][Full Text] [Related]
29. Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.
Hessell AJ; Shapiro MB; Powell R; Malherbe DC; McBurney SP; Pandey S; Cheever T; Sutton WF; Kahl C; Park B; Zolla-Pazner S; Haigwood NL
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514914
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of virus production in peripheral blood mononuclear cells from human immunodeficiency virus (HIV) type 1-seropositive donors by treatment with recombinant HIV-like particles.
Haffar OK; Moran PA; Smithgall MD; Diegel ML; Sridhar P; Ledbetter JA; Zarling JM; Hu SL
J Virol; 1992 Jul; 66(7):4279-87. PubMed ID: 1602544
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
32. Differential effect of anti-beta 2-microglobulin on IL 2 production and IL 2 receptor expression in the primary mixed lymphocyte culture reaction.
Chouaib S; Welte K; Dupont B
J Immunol; 1985 Feb; 134(2):940-8. PubMed ID: 3155544
[TBL] [Abstract][Full Text] [Related]
33. Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies.
Burkly L; Mulrey N; Blumenthal R; Dimitrov DS
J Virol; 1995 Jul; 69(7):4267-73. PubMed ID: 7769687
[TBL] [Abstract][Full Text] [Related]
34. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro.
Saha K; Bentsman G; Chess L; Volsky DJ
J Virol; 1998 Jan; 72(1):876-81. PubMed ID: 9420304
[TBL] [Abstract][Full Text] [Related]
35. Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site.
Vijh-Warrier S; Pinter A; Honnen WJ; Tilley SA
J Virol; 1996 Jul; 70(7):4466-73. PubMed ID: 8676471
[TBL] [Abstract][Full Text] [Related]
36. In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.
Chehimi J; Bandyopadhyay S; Prakash K; Perussia B; Hassan NF; Kawashima H; Campbell D; Kornbluth J; Starr SE
J Virol; 1991 Apr; 65(4):1812-22. PubMed ID: 1672164
[TBL] [Abstract][Full Text] [Related]
37. An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells.
Benkirane M; Corbeau P; Housset V; Devaux C
EMBO J; 1993 Dec; 12(13):4909-21. PubMed ID: 7505220
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to human and non-human primate cellular and culture medium components in macaques vaccinated with the simian immunodeficiency virus.
Bergmeier LA; Walker J; Tao L; Cranage M; Lehner T
Immunology; 1994 Oct; 83(2):213-20. PubMed ID: 7835937
[TBL] [Abstract][Full Text] [Related]
39. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.
Purtscher M; Trkola A; Gruber G; Buchacher A; Predl R; Steindl F; Tauer C; Berger R; Barrett N; Jungbauer A
AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1651-8. PubMed ID: 7888224
[TBL] [Abstract][Full Text] [Related]
40. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC).
Christiaansen JE; Burnside SS; Sears DW
J Immunol; 1987 Apr; 138(7):2236-43. PubMed ID: 3549899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
